Taro Pharmaceuticals U.S.A., Inc.
78
Plan:
Taro Pharmaceuticals U.S.A., Inc. 401k Plan
40
65
88
0
10
20
30
40
50
60
70
80
90
100
For the average 401k participant, the 10 point difference between this plan's BrightScope Rating (78) and the top rated plan (88) could equate to:
[How is this calculated?]
[How is this calculated?]
7 additional years of work Up to $2,400 in lost retirement savings.The delay in retirement calculations apply solely to this defined contribution plan and do not take into account other retirement plans and programs offered by this employer.
Retirement Plan Description
Taro Pharmaceuticals U.S.A., Inc. 401k Plan is a defined contribution plan with a 401k feature. This plan has a BrightScope Rating of 78, placing it in the top 15% of all plans in its peer group. This plan is also in the top 15% of plans for Salary Deferral. Taro Pharmaceuticals U.S.A., Inc. 401k Plan currently has over 300 active participants and over $16.1M in plan assets.
Retirement Plan Details
| Address |
3 Skyline Drive
Hawthorne, NY 10532 |
| Industry | Drugs and Druggists' Sundries Merchant Wholesalers |
| Administrator | Michele Visosky |
| Net Plan Assets | $16,100,000 |
| Total Participants | 350 |
| Avg Account Balance | $46,000 |
Compare Other Companies in Peer Group
| EMD Chemicals | 78.9 |
| Obagi Medical Products | 76.2 |
| Herbalife International of America | 72.0 |
| Sunrider International | 69.8 |
| Morris & Dickson Co., Ltd. | 68.6 |
| DEGC Enterprises | 57.6 |
Comments